
NYSEConsumer DefensiveHousehold & Personal Products
Latest quote
$3.80
+$0.03 · +0.80%
Nu Skin Enterprises, Inc. (NUS) is a global enterprise dedicated to the creation and worldwide distribution of beauty and wellness solutions. The company's diverse product offerings encompass advanced skincare systems, such as the ageLOC Spa and ageLOC Transformation age-defying lines, innovative devices like the ageLOC LumiSpa for comprehensive skin treatment and cleansing, and the ageLOC Boost, alongside various other cosmetic and personal care items. In the realm of health and nutrition, Nu Skin provides a comprehensive array of dietary and weight management products. This includes ageLOC Youth, LifePak, and ageLOC Meta nutritional supplements, in addition to ageLOC TR90 programs designed for weight control and body contouring, Beauty Focus Collagen+ skin care supplements, and other related weight management aids. The organization also significantly invests in research and development, particularly for its skincare and nutritional supplement portfolios. Nu Skin operates a network of retail stores and customer service centers exclusively within Mainland China. Its extensive product lines are marketed under its proprietary brands, which include Nu Skin, Pharmanex, and ageLOC. These products reach consumers through multiple sales channels, including direct-to-consumer interactions, an extensive network of independent distributors, and its dedicated e-commerce platform. Nu Skin Enterprises, Inc. was established in 1984 and maintains its corporate headquarters in Provo, Utah.
Previous close
$3.80
+$0.03 · +0.80%
Regular session · ET · Market data may be delayed.
Nu Skin Enterprises, Inc. (NUS) is a global enterprise dedicated to the creation and worldwide distribution of beauty and wellness solutions. The company's diverse product offerings encompass advanced skincare systems, such as the ageLOC Spa and ageLOC Transformation age-defying lines, innovative devices like the ageLOC LumiSpa for comprehensive skin treatment and cleansing, and the ageLOC Boost, alongside various other cosmetic and personal care items. In the realm of health and nutrition, Nu Skin provides a comprehensive array of dietary and weight management products. This includes ageLOC Youth, LifePak, and ageLOC Meta nutritional supplements, in addition to ageLOC TR90 programs designed for weight control and body contouring, Beauty Focus Collagen+ skin care supplements, and other related weight management aids. The organization also significantly invests in research and development, particularly for its skincare and nutritional supplement portfolios. Nu Skin operates a network of retail stores and customer service centers exclusively within Mainland China. Its extensive product lines are marketed under its proprietary brands, which include Nu Skin, Pharmanex, and ageLOC. These products reach consumers through multiple sales channels, including direct-to-consumer interactions, an extensive network of independent distributors, and its dedicated e-commerce platform. Nu Skin Enterprises, Inc. was established in 1984 and maintains its corporate headquarters in Provo, Utah.
Day range
Current $3.80
52-week range
Current $3.80
Regular session · ET · Market data may be delayed.
GoAI Score
Hold
Valuation
92
Deep Value
Sentiment
60
Mixed
Risk
60
Elevated Risk
Momentum
23
Weakening
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Nu Skin Enterprises, Inc. (NUS) is a global enterprise dedicated to the creation and worldwide distribution of beauty and wellness solutions. The company's diverse product offerings encompass advanced skincare systems, such as the ageLOC Spa and ageLOC Transformation age-defying lines, innovative devices like the ageLOC LumiSpa for comprehensive skin treatment and cleansing, and the ageLOC Boost, alongside various other cosmetic and personal care items. In the realm of health and nutrition, Nu Skin provides a comprehensive array of dietary and weight management products. This includes ageLOC Youth, LifePak, and ageLOC Meta nutritional supplements, in addition to ageLOC TR90 programs designed for weight control and body contouring, Beauty Focus Collagen+ skin care supplements, and other related weight management aids. The organization also significantly invests in research and development, particularly for its skincare and nutritional supplement portfolios. Nu Skin operates a network of retail stores and customer service centers exclusively within Mainland China. Its extensive product lines are marketed under its proprietary brands, which include Nu Skin, Pharmanex, and ageLOC. These products reach consumers through multiple sales channels, including direct-to-consumer interactions, an extensive network of independent distributors, and its dedicated e-commerce platform. Nu Skin Enterprises, Inc. was established in 1984 and maintains its corporate headquarters in Provo, Utah.
Day range
Current $3.80
52-week range
Current $3.80
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.49B USD | 1.73B USD | 1.97B USD | 2.23B USD | 2.7B USD |
| Cost of goods sold | 453.76M USD | 550.23M USD | 611.85M USD | 630.92M USD | 675.22M USD |
| Gross profit | 1.03B USD | 1.18B USD | 1.36B USD | 1.59B USD | 2.02B USD |
| Research and development | — | 13M USD | 22.6M USD | — | 27.2M USD |
| Selling, general, and administrative | 940.52M USD | 1.13B USD | 1.29B USD | 1.44B USD | 1.73B USD |
| Operating expenses | 940.52M USD | 1.33B USD | 1.31B USD | 1.48B USD | 1.79B USD |
| Interest income | — | — | — | 10.38M USD | 11.16M USD |
| Interest expense | 13.95M USD | 26.41M USD | 25.56M USD | 21.88M USD | 11M USD |
| Depreciation and amortization | 52.26M USD | 69.81M USD | 70.92M USD | 72.51M USD | 76.32M USD |
| Operating income | 90.88M USD | −151.59M USD | 48.27M USD | 110.85M USD | 233.99M USD |
| Net income | 160.2M USD | −146.59M USD | 8.6M USD | 104.78M USD | 147.27M USD |
Company facts updated Nov 22, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Average target
$11.00
189.47% upsideFunds reporting this stock among their holdings, ordered by reported position size.
Avantis U.S. Small Cap Value ETFAVUV9.88M0.03%30.51B USD0.25%$114.4-1.82%
Vanguard Morningstar Total Stock Market ETFVTI5.37M0.00%689.3B USD0.03%$340.02-3.52%
iShares Russell 2000 ETFIWM5.22M0.01%71.54B USD0.19%$256.61-2.88%
Vanguard Extended Market ETFVXF2.61M0.00%30.2B USD0.05%$211.44-3.21%
Vanguard Consumer Staples ETFVDC2.55M0.03%8.1B USD0.09%$247.1+0.61%
U.S. Small Cap Value Portfolio ETF Class SharesDFSV2.03M0.01%25.71B USD0.31%$36.63-2.01%
Schwab Fundamental U.S. Small Company Index ETFFNDA1.97M0.02%8.36B USD0.25%$33.85-2.31%
iShares Russell 2000 Value ETFIWN1.89M0.01%13.05B USD0.24%$198.84-2.08%
Avantis U.S. Small Cap Value ETFAVUV
Vanguard Morningstar Total Stock Market ETFVTI
iShares Russell 2000 ETFIWM
Vanguard Extended Market ETFVXF
Vanguard Consumer Staples ETFVDC
U.S. Small Cap Value Portfolio ETF Class SharesDFSV
Schwab Fundamental U.S. Small Company Index ETFFNDA
iShares Russell 2000 Value ETFIWNAI-generated and delayed market data for informational and educational purposes only. Not investment advice.